Novel therapeutic agents in the treatment of metastatic colorectal cancer - Wikidata - awgldk - TriplyDB

Novel therapeutic agents in the treatment of metastatic colorectal cancer

Novel therapeutic agents in the treatment of metastatic colorectal cancer

http://www.wikidata.org/entity/Q26769932

about

Guanylyl cyclase C signaling axis and colon cancer prevention Activins and their related proteins in colon carcinogenesis: insights from early and advanced azoxymethane rat models of colon cancer Immunoglobulin E induces colon cancer cell apoptosis via enhancing cyp27b1 expression.TRIM21 is a novel regulator of Par-4 in colon and pancreatic cancer cells MicroRNAs as outcome predictors in patients with metastatic colorectal cancer treated with bevacizumab in combination with FOLFOX.Guanylate cyclase C as a target for prevention, detection, and therapy in colorectal cancer.LRP6 promotes invasion and metastasis of colorectal cancer through cytoskeleton dynamics.Cost-effectiveness of Colorectal Cancer Screening and Treatment Methods: Mapping of Systematic Reviews.

P2860

Q28074181-8B74D8CB-C332-4C1C-8B35-62AE6D5F4201 Q36190270-3B69A4D3-86AC-4187-8FF0-23B852F207AF Q37553888-B58AED62-93CF-4A27-AF28-DA0C9B745B47 Q37662004-279E079B-3BDB-4852-92C2-046E5103478A Q38686019-C437F988-4AED-49D2-995F-C94DDF18EE92 Q39120155-37CB40D8-E64C-4553-8ABD-DAAD972DE110 Q47220360-BBD761B8-9A05-49A0-BCBD-ACC727577F8D Q47551962-A5F79B23-87A6-4A5E-BA73-18007CA1AF5C

P2860

Novel therapeutic agents in the treatment of metastatic colorectal cancer

http://www.wikidata.org/entity/Q26769932

description

2016 nî lūn-bûn

@nan

2016 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Novel therapeutic agents in the treatment of metastatic colorectal cancer

@ast

Novel therapeutic agents in the treatment of metastatic colorectal cancer

@en

Novel therapeutic agents in the treatment of metastatic colorectal cancer

@nl

type

label

Novel therapeutic agents in the treatment of metastatic colorectal cancer

@ast

Novel therapeutic agents in the treatment of metastatic colorectal cancer

@en

Novel therapeutic agents in the treatment of metastatic colorectal cancer

@nl

prefLabel

Novel therapeutic agents in the treatment of metastatic colorectal cancer

@ast

Novel therapeutic agents in the treatment of metastatic colorectal cancer

@en

Novel therapeutic agents in the treatment of metastatic colorectal cancer

@nl

P1433

Q26769932-F25B0AC0-CB35-464D-A6C8-D2D4353ED8DD

P1476

Q26769932-EF454AA4-38B6-4D39-AE60-6F09ED1366BC

P2093

Q26769932-9A72EA7F-9056-4AB8-942F-31478A23DCFD

P2860

Q26769932-002DDB5D-08AD-4CA7-AC40-C1E970CFE6AF

Q26769932-09573E04-2A3E-4D73-8E28-73181B816A92

Q26769932-15191B43-8845-412D-BBBD-14C3655015C1

Q26769932-1CB6E778-C610-4D85-B234-8A6824197161

Q26769932-2202DD19-072D-4D18-9CC7-C1BAC64B271B

Q26769932-25938D39-0407-4788-A805-B8FA905D5A4C

Q26769932-25BF31A0-B1A0-4F26-BE37-36174D2F7A8C

Q26769932-329BB9A3-3559-4576-AC86-582A00ED488F

Q26769932-36216EC5-7318-447F-84DD-8CCE095F5A76

Q26769932-3BB26A0E-E1AB-4931-9AAE-D21A4F055C95

P304

Q26769932-6DFA34A2-CDF7-4094-82A7-CF1DCCF22E3A

P31

Q26769932-E7B0FE09-3914-43FB-B20B-42031AE0E031

P3181

Q26769932-94076B11-401C-4110-8F13-A97639BCF8B8

P356

Q26769932-5EE978FE-7AF0-44FC-9A19-E0E890B29696

P407

Q26769932-4867B118-A0F2-4B15-90F8-0A01161685D0

P433

Q26769932-DCF657C9-9ED4-4231-BFEE-6DC9BF21E13C

P478

Q26769932-07E9C11B-E7DF-4E43-BFEC-1C24810FF98E

P50

Q26769932-EFC88204-B5F8-4A8C-8CA0-2A2381FF485F

P577

Q26769932-539E5B50-597E-4326-8E41-37A37AB4FF1C

P5875

Q26769932-D01186F3-79F1-4DC8-B332-96910DA649D1

P698

Q26769932-E1D2C139-174B-418C-99BD-05DA53453374

P921

Q26769932-565CBCCC-47C6-4BBE-AEBD-91EAE02EE24F

P932

Q26769932-277577F5-6218-44DF-A5B3-5028C93E48A3

P3181

P356

P1433

World journal of gastrointestinal oncology

P1476

Novel therapeutic agents in the treatment of metastatic colorectal cancer

@en

P2093

Jyotsna Fuloria

http://www.w3.org/2001/XMLSchema#string

P2860

Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR.

Pilot trial of combined BRAF and EGFR inhibition in BRAF-mutant metastatic colorectal cancer patients.

Tumor angiogenesis: therapeutic implications

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): a randomised, multicentre, open-label, non-inferiority phase 3 study

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer

Vascular endothelial growth factor is a secreted angiogenic mitogen

Regorafenib assessment in refractory advanced colorectal cancer: RegARd-C study protocol

Role of angiogenesis in tumor growth and metastasis

P304

99-104

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2586402

http://www.w3.org/2001/XMLSchema#string

P356

10.4251/WJGO.V8.I1.99

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

290472001

http://www.w3.org/2001/XMLSchema#string

P698

26798440

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

4714150

http://www.w3.org/2001/XMLSchema#string